Status:
RECRUITING
Factors Influencing Adherence to Adjuvant Endocrine Therapy
Lead Sponsor:
University of Zagreb
Conditions:
Adherence, Treatment
Eligibility:
FEMALE
18+ years
Brief Summary
Breast cancer is the most common type of cancer and the leading cause of cancer death in women. Adjuvant endocrine therapy (AET) reduces the risk of disease recurrence and mortality in women with horm...
Eligibility Criteria
Inclusion
- women older than 18 years of age
- clinical diagnosis of hormone receptor positive early breast cancer stages 0-III according to the American Joint Committee on Cancer (AJCC) classification
- prescribed with adjuvant endocrine therapy for more than 3 months
Exclusion
- advanced metastatic breast cancer, stage IV according to the American Joint Committee on Cancer (AJCC) classification
- other life-threatening illnesses
- mental disorders
- behavioral disorders caused by the use of psychoactive substances
- behavioral syndromes related to physiological disorders and physical factors
- cognitive impairment
- organic and symptomatic mental disorder
- schizophrenia
- disorders similar to schizophrenia
- delusional disorders
- personality disorders
- behavior disorders
- mental retardation
- psychological development disorders
- unspecified mental disorders
- Incapable of autonomously reaching decisions
Key Trial Info
Start Date :
September 20 2021
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
September 20 2024
Estimated Enrollment :
1000 Patients enrolled
Trial Details
Trial ID
NCT06192446
Start Date
September 20 2021
End Date
September 20 2024
Last Update
January 11 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University of Zagreb Faculty of Pharmacy and Biochemistry
Zagreb, Croatia, 10000